Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07731555) titled 'Characterization of the Blood-Brain Barrier in High-Grade Glioma Through Immunohistochemical, Transcriptional, Fluorescein and Radiological Analyses' on July 22.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: Patrick Morris
Condition:
Glioblastoma
Intervention:
Diagnostic Test: Multimodal Blood Brain Barrier Assessment
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: March 1, 2022
Target Sample Size: 100
Countries of Recruitment:
Ireland
To know more, visi...